Programme

To download a PDF of the programme click here.

For further information on this event please contact us.

Day One

Tuesday 27th June 2023

08.15 onwards
Registration and Poster Set-Up

09.45-10.00
Welcome to Riga and Opening Remarks
Kaspars Tars
(Latvian Biomedical Research and Study Center, Riga, Latvia)

SESSION 1:
OPENING PLENARY SESSION

Moderator: Kaspars Tars
(Latvian Biomedical Research and Study Center, Riga, Latvia)

10.00-10.40
KEYNOTE:
‘Pushing the envelope of HIV-1 vaccine design’

Richard Wyatt
(Scripps Research Institute, La Jolla, California, USA)

10.40-11.20
‘Malaria Vaccines targeting vulnerable epitopes in CSP’
Lucie Jelinkova1, Yevel Flores-Garcia2, Yogesh Nepal1, Bryce Roberts1, Alexandra Francian1, Rabia Khan1, Fidel Zavala2 and Bryce Chackerian1
(1 University of New Mexico School of Medicine, Albuquerque, New Mexico, USA; 2 Johns Hopkins University, Baltimore, Maryland, USA)

11.20-12.00
Coffee Break & Posters

12.00-12.30
KEYNOTE: 
‘Polio and the need for non infectious vaccines such as VLPs’

Martin Eisenhauer
(World Health Organisation, Geneva, Switzerland)

12.30-13.00
KEYNOTE:
‘A next generation Alzheimers vaccine’

Martin Bachmann
(University of Bern, Bern, Switzerland/University of Oxford, Oxford, UK)

13.00-14.00
Lunch Break & Posters

SESSION 2:
DESIGN/DEVELOPMENT/PRODUCTION

Moderator: Bryce Chackerian
(University of New Mexico School of Medicine, Albuquerque, New Mexico, USA)

14.00-14.30
‘VLPs of ssRNA phages: Diversity, structure and applications in vaccine development’
Kaspars Tars
(Latvian Biomedical Research and Study Center, Riga, Latvia)

14.30-15.00
‘Design of hepatitis B virus-like particles (VLPs) to optimise immunisation outcomes for preventative or therapeutic applications
Hans Netter
(Peter Doherty Institute, Melbourne, Victoria, Australia)

15.00-15.30
‘Polio VLP development consortium presentation’
Nicola Stonehouse
(University of Leeds, Leeds, UK)

15.30-16.00
Tea Break & Posters

SESSION 3:
VLP VACCINES

Moderator: Martin Eisenhauer
World Health Organisation WHO, Geneva, Switzerland)

16.00-16.30
KEYNOTE:
‘VLP-based vaccines for cardiovascular disease

Alexandra Fowler1, Erin Crossey1, Maureen Sampson2, Marcelo Amar2, John Schiller3, Koen Van Rompay4, Alan Remaley2 and Bryce Chackerian1
(1 University of New Mexico School of Medicine, Albuquerque, New Mexico, USA; 2 NIH/NHLBI, Bethesda, Maryland, USA; 3 NIH/NCI, Bethesda, Maryland, USA; 4 California Regional Primate Center, Davis, California, USA)

16.30-17.00
‘Expression and evaluation of coat proteins derived from thermophilic bacteriophages for assembly into virus-like particles’
Lukai Zhai1,2, Rashi Yadav1,3 and Ebenezer Tumban1,4
( 1 Michigan Technological University, Houghton, Michigan, USA; 2 Current address: Department of metabolism and nutritional programming, Van Andel Research Institute, Grand Rapids, Michigan, USA; 3 Current address: Oregon Health and Science University, Portland, Oregon, USA: 4 Current address: Texas Tech University School of Veterinary Medicine, Amarillo, Texas, USA)

17.00-17.30
‘Exploiting Pichia pastoris for production of a VLP vaccine against poliomyelitis’
Jessica Swanson1, Lee Sherry1, Keith Grehan1, Kirsty Sawtell1, Helen Fox2, Mohammad W. Bahar3, Elizabeth E. Fry3, David I. Stuart3, Andrew J. Macadam2, David J. Rowlands1 and Nicola J. Stonehouse1
(1 School of Molecular and Cellular Biology, University of Leeds, Leeds, UK; 2 Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, UK; 3 Division of Structural Biology, University of Oxford, Oxford, UK)

17.30-17.50
‘POLIO ALERT – An Old Disease resurfaces in the world’
Micha Roumiantzeff, Joël Calmet and Konstantin Chumakov
(Michadvices, Lyon, France)

17.50-19.00
VLPNPV 2023 Welcome Drinks Reception & Posters
Sponsored by BIOSAN

Biosan

 

Day Two

Day Three

Posters

This final programme is correct at the time of publication. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the conference programme.